Contact

Merge Healthcare Launches Enhanced PACS To Meet The Needs Of Enterprise Health Systems and Tele-radiology merge pacs, teleradiology, tomosynthesis, cacheless pacs, pacs update Merge PACS 7.0 delivers composite worklists for unrivaled reading efficiency, cacheless PACS operations on industry leading VNA and enhanced mammo tomosynthesis viewing

Merge Healthcare Launches Enhanced PACS To Meet The Needs Of Enterprise Health Systems and Tele-radiology

Merge PACS 7.0 delivers composite worklists for unrivaled reading efficiency, cacheless PACS operations on industry leading VNA and enhanced mammo tomosynthesis viewing

Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced new capabilities and enhancements to Merge PACS, specifically designed to support enterprise health systems and tele-radiology.

Enhancements to Merge PACS 7.0 are a result of ongoing collaboration between Merge and its customers, honing in on the capabilities that will be most valuable for improving operational workflow and preparing organizations for the future of interoperability.

“We’ve worked with Merge for more than 10 years and are particularly looking forward to this new release for our PACS due to the enhanced work list features and macro capabilities,” said Jay Mosser, Enterprise System Architect at Radiology Associates LLP of Corpus Christi.  “For us, the operational enhancements will really streamline workflow and provide greater access to the imaging data needed for our radiologists to provide services quickly. With referral leakage and interoperability top of mind for healthcare organizations, the new system will be critical for us to meet those needs while enhancing quality care for patients.”

By directly integrating with the market leading iConnect Enterprise Archive, Merge PACS 7.0 provides access to all studies available for a patient, eliminating the need for pre-fetching. Additional benefits include:

  • Efficient high volume reading enabled by worklist driven pre-caching of upcoming studies, which are automatically pulled to the user;
  • Flexible enterprise user management through templated user settings  that automatically establish preferences and allow for administrative updates without compromising user logins;
  • Enhanced mammography Tomosynthesis viewing with stack position indicator, thick slab viewing, and MPR; and
  • Accelerated workflow due to macros that can also be used for customer created integrations with other applications.

“This new system is a direct result of our ongoing commitment to customers to build solutions which support their diverse business environments. PACS 7.0 brings our client requirements into one flexible solution that scales to meet our largest customer requirements,” said Justin Dearborn, CEO at Merge Healthcare. “We are looking forward to having all of our imaging clients benefit from this new release.”

To learn more about Merge PACS 7.0, stop by Merge booth #1329 at the RSNA Annual Meeting November 30 through December 5.

About Merge
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare.

Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Contact:
Steven Tolle
Chief Strategy Officer
312.946.2503
steven.tolle@merge.com

 Download this press release >>

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap